Predicting Outcomes With Pembrolizumab: a Meta-Analysis of Pre-Treatment Hematological and Clinical Prognostic Factors in Advanced Metastatic Urothelial Carcinoma. Arch Ital Urol Androl 2025, 97 (2). https://doi.org/10.4081/aiua.2025.13880.